RUCAPARIB CAMSYLATE for Neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 56 adverse event reports in the FDA FAERS database where RUCAPARIB CAMSYLATE was used for Neoplasm malignant.

Most Reported Side Effects for RUCAPARIB CAMSYLATE

Side Effect	Reports	%	Deaths	Hosp.
Fatigue	2,494	30.3%	40	335
Nausea	2,219	26.9%	40	333
Malignant neoplasm progression	1,162	14.1%	69	139
Decreased appetite	787	9.6%	17	148
Constipation	763	9.3%	12	123
Diarrhoea	759	9.2%	19	109
Vomiting	759	9.2%	24	184
Asthenia	660	8.0%	24	148
Adverse event	571	6.9%	22	269
Carbohydrate antigen 125 increased	562	6.8%	10	85
Dysgeusia	558	6.8%	8	86
Product dose omission issue	542	6.6%	2	42
Platelet count decreased	527	6.4%	6	100
Anaemia	496	6.0%	14	114
Drug ineffective	490	6.0%	13	41